Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-020827
Filing Date
2018-11-14
Accepted
2018-11-14 16:17:58
Documents
64
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q kool20180930_10q.htm 10-Q 781574
2 EXHIBIT 31.1 ex_129082.htm EX-31.1 8735
3 EXHIBIT 31.2 ex_129083.htm EX-31.2 8847
4 EXHIBIT 32 ex_129084.htm EX-32 6024
  Complete submission text file 0001437749-18-020827.txt   5597611

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT kool-20180930.xml EX-101.INS 1350092
6 XBRL TAXONOMY EXTENSION SCHEMA kool-20180930.xsd EX-101.SCH 55226
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kool-20180930_cal.xml EX-101.CAL 38665
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kool-20180930_def.xml EX-101.DEF 379830
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE kool-20180930_lab.xml EX-101.LAB 342099
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kool-20180930_pre.xml EX-101.PRE 410269
Mailing Address 2711 CITRUS ROAD RANCHO CORDOVA CA 95742
Business Address 2711 CITRUS ROAD RANCHO CORDOVA CA 95742 9168585100
CESCA THERAPEUTICS INC. (Filer) CIK: 0000811212 (see all company filings)

EIN.: 943018487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-82900 | Film No.: 181184028
SIC: 3821 Laboratory Apparatus & Furniture